ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 118 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | 0.0% | 469 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $5,000 | +25.0% | 469 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $4,000 | -42.9% | 469 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $7,000 | -41.7% | 469 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $12,000 | +20.0% | 469 | +17.2% | 0.01% | +25.0% |
Q2 2021 | $10,000 | -28.6% | 400 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $14,000 | +40.0% | 400 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $10,000 | -33.3% | 400 | 0.0% | 0.01% | -44.4% |
Q3 2020 | $15,000 | -11.8% | 400 | 0.0% | 0.01% | -18.2% |
Q2 2020 | $17,000 | +112.5% | 400 | 0.0% | 0.01% | +83.3% |
Q1 2020 | $8,000 | -20.0% | 400 | 0.0% | 0.01% | +20.0% |
Q4 2019 | $10,000 | -9.1% | 400 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $11,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $11,000 | -8.3% | 400 | 0.0% | 0.01% | -14.3% |
Q1 2019 | $12,000 | +9.1% | 400 | 0.0% | 0.01% | -12.5% |
Q4 2018 | $11,000 | – | 400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |